VIR Latest Headlines

Vir Biotechnology Sets Sights on March Investor Conferences to Spotlight Its Advancing Pipeline

Market Chameleon (Fri, 27-Feb 8:57 AM)

Vir Biotechnology Launches $200 Million Public Share Offering to Fund Next Phase in Infectious Disease and Oncology Research

Market Chameleon (Wed, 25-Feb 10:37 AM)

Vir Biotechnology Targets $200 Million in New Funding with Public Stock Offering — What Does It Signal for Future Growth?

Market Chameleon (Wed, 25-Feb 7:32 AM)

Strategic Partnerships and Pipeline Progress Strengthen Vir Biotechnology’s Outlook Despite Continued Losses

Market Chameleon (Tue, 24-Feb 9:53 AM)